Delivery Order SPE2DB22D2206-SPE2DB25FGT02

Award Date 4/25/25
Potential Completion Date 5/16/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,325.14 Firm Fixed Price Delivery Order contract is for the supply of 4567985861 TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of May 12, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,508.31, is a delivery order for the supply of TAGRISSO 40 MG TABLET 30S, a medical product. The contract has a completion date of January 29, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $21,325.14 with a firm fixed price, and an ultimate completion date of April 29, 2025. The contract covers the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $31,987.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Tagrisso 80 mg tablet, with an ultimate completion date of May 13, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,641.07 firm fixed-price delivery order is for TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,662.57 firm fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $10,508.31, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product, with a completion date of June 11, 2024. The contract is a Delivery Order and is a Firm Fixed Price type. This award is associated with a larger Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $21,047.10, is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $42,033.24 firm-fixed-price delivery order is for the supply of TAGRISSO 40 MG TABLET 30S, a specialty medication. The contract has a completion date of September 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $10,538.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is August 7, 2024. The contract covers the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGT02
    Delivery Order

This federal contract award, valued at $21,325.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4568038873 - TAGRISSO 80 MG TABLET 30S, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a performance period through May 16, 2025.

AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/25/25, 11:30 AM